Retrospective analysis of anti-VEGF intravitreal injection

Retrospective analysis of anti-VEGF intravitreal injection

AIM: To study the application of intravitreal injection of anti-vascular endothelial growth factor(VEGF)inpatients with fundus neovascularization disease in No.2 Foshan People's Hospital between 2013 to 2015. <p>METHODS: Retrospective analysis of inpatients of Foshan Second People's...

Full description

Bibliographic Details
Main Authors:	Hai-Zhi Ma, Yong-Zhe Tang, Huai-Sheng Zhou, Shi-Gang Yan
Format:	Article
Language:	English
Published:	Press of International Journal of Ophthalmology (IJO PRESS) 2017-03-01
Series:	Guoji Yanke Zazhi
Subjects:	anti-VEGF intravitreal injection retrospective analysis fundus neovascular diseases
Online Access:	http://ies.ijo.cn/cn_publish/2017/3/201703046.pdf

Similar Items

Impact of Delayed Intravitreal Anti-Vascular Endothelial Growth Factor (VEGF) Therapy Due to the Coronavirus Disease Pandemic on the Prognosis of Patients with Neovascular Age-Related Macular Degeneration
by: Jae-Gon Kim, et al.
Published: (2022-04-01)

Visual Outcome after Intravitreal Anti-VEGF Therapy for Macular Neovascularisation Secondary to Sorsby’s Fundus Dystrophy: A Systematic Review
by: Arthur Baston, et al.
Published: (2021-05-01)

Intravitreal Anti-Vascular Endothelial Growth Factor Therapies for Retinal Disorders
by: Abraham Hang, et al.
Published: (2023-08-01)

Effective study in the real-world study of intravitreal anti-VEGF drugs injection in the treatment of fundus diseases
by: Jian-Feng Xu, et al.
Published: (2017-09-01)

Intravitreal injection of Conbercept combined with trabeculectomy and panretinal photocoagulation for the treatment of neovascular glaucoma
by: Zhe Yu, et al.
Published: (2018-05-01)

Profile of Patients Treated with Intravitreal Anti-Vascular Endothelial Growth Factor Injections in Bhutan
by: Rai BB, et al.
Published: (2023-06-01)

Bacterial endophthalmitis following anti-VEGF intravitreal injections: a retrospective case series
by: Vinicius Campos Bergamo, et al.
Published: (2023-09-01)

Long-term outcomes of intravitreal anti-VEGF therapies in patients affected by neovascular age-related macular degeneration: a real-life study
by: Paolo Corazza, et al.
Published: (2021-08-01)

Delaying anti-VEGF therapy during the COVID-19 pandemic: long-term impact on visual outcomes in patients with neovascular age-related macular degeneration
by: Marco Nassisi, et al.
Published: (2023-04-01)

Multiple Intravitreal Ranibizumab Injections for Persistant Choroidal Neovascularization Associated with Presumed Ocular Histoplasmosis Syndrome
by: Turgut Yılmaz, et al.
Published: (2017-03-01)

Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture
by: T. Barth, et al.
Published: (2019-11-01)

Recurrence of Macular Hole Retinal Detachment after Intravitreal Ranibizumab Injection for the Treatment of Choroidal Neovascularization from the Remaining Macular Hole Edge
by: Keiko Otsuka, et al.
Published: (2012-12-01)

Results of Intravitreal Anti-VEGF Injection in Choroidal Neovascularization Caused by Pathologies Other Than Age-Related Macular Degeneration
by: Mehmet Ozveren
Published: (2020-08-01)

Intravitreal Bevacizumab injection combined duplex technique in treatment of neovascular glaucoma
by: Zheng-Jun Hu, et al.
Published: (2015-05-01)

Intravitreal bevacizumab and Ahmed glaucoma valve implantation in patients with neovascular glaucoma
by: Hai-Tao Zhang, et al.
Published: (2014-10-01)

Evaluation of efficacy and recurrence for anti-vascular endothelial growth factor therapy in idiopathic choroidal neovascularization
by: Qianru Wu, et al.
Published: (2020-03-01)

Hypotony Maculopathy Related to Anti-VEGF Intravitreal Injection
by: Lima-Fontes M, et al.
Published: (2022-09-01)

Intravitreal topotecan inhibits laser-induced choroidal neovascularization in a rat model
by: Mohammad Ali Gholipour, et al.
Published: (2015-01-01)

Treatment of myopic choroidal neovascularization with intravitreal ranibizumab injections: the role of age
by: Karagiannis D, et al.
Published: (2017-06-01)

Role of FGF and Hyaluronan in Choroidal Neovascularization in Sorsby Fundus Dystrophy
by: Alyson Wolk, et al.
Published: (2020-03-01)

Prevalence and implications of the presence of intraocular silicone oil droplets in patients treated with intravitreal injections of anti-VEGF
by: Sandra Banderas García, et al.
Published: (2022-07-01)

Bilateral Hypertensive Retinopathy Complicated with Retinal Neovascularization: Panretinal Photocoagulation or Intravitreal Anti-VEGF Treatment
by: Odysseas Georgiadis, et al.
Published: (2014-07-01)

INTRAVITREAL INTRODUCTION OF LUCENTIS AND TRANS-SCLERAL CYCLOPHOTOCOAGULATION IN THE TREATMENT OF NEOVASCULAR GLAUCOMA IN DIABETES MELLITUS
by: V. P. Fokin, et al.
Published: (2016-11-01)

Pharmacogenomic study on anti-VEGF medicine in treatment of macular Neovascular diseases: a study protocol for a prospective observational study
by: Jin Jing, et al.
Published: (2018-07-01)

Therapeutic effect of photodynamic therapy and intravitreal injection with ranibizumab for choroidal neovascularization of pathologic myopia
by: Cong Zhang, et al.
Published: (2014-07-01)

Bevacizumab: Off-label use in ophthalmology
by: Grisanti Salvatore, et al.
Published: (2007-01-01)

A Review of Neovascular Glaucoma: Etiology, Pathogenesis, Diagnosis, and Treatment
by: Danielė Urbonavičiūtė, et al.
Published: (2022-12-01)

Application of the intravitreal Ranibizumab combined with retinal photocoagulation for the neovascular glaucoma
by: Fen-Dui Zhang, et al.
Published: (2015-05-01)

Safety of bilateral same-day intravitreal injections of anti-vascular endothelial growth factor agents
by: Ruão M, et al.
Published: (2017-02-01)

A Case of Choroidal Neovascularization Secondary to Unilateral Retinal Pigment Epithelium Dysgenesis
by: Tsuyoshi Shimoyama, et al.
Published: (2014-01-01)

Clinical research of intravitreal injection of Conbercept combined with different methods in the treatment of neovascular glaucoma
by: Li-Ping Wang, et al.
Published: (2017-02-01)

Peripapillary Choroidal Neovascularization Associated with Optic Nerve Head Drusen Treated with Anti-VEGF Agents
by: Norman A. Saffra, et al.
Published: (2015-02-01)

Is tacrolimus effective against choroidal neovascularization? A preliminary study
by: Muhamet Kivilcim, et al.
Published: (2023-06-01)

Macular hole retinal detachment after intravitreal Conbercept injection for the treatment of choroidal neovascularization secondary to degenerative myopia: a case report
by: Chuan-bin Sun, et al.
Published: (2019-07-01)

Use of Artificial Tears in Patients Undergoing Treatment with Anti-VEGF Intravitreal Injections
by: Pastor-Pascual F, et al.
Published: (2022-11-01)

Study protocol for prognosis and treatment strategy of peripheral persistent avascular retina after intravitreal anti-VEGF therapy in retinopathy of prematurity
by: Ying Yu, et al.
Published: (2020-06-01)

Neovascular Remodeling and Subretinal Fibrosis as Biomarkers for Predicting Incomplete Response to Anti-VEGF Therapy in Neovascular Age-Related Macular Degeneration
by: Jing Wu, et al.
Published: (2022-04-01)

Pharmacokinetic and Pharmacodynamic Rationale for Extending VEGF Inhibition Increasing Intravitreal Aflibercept Dose
by: Daniele Veritti, et al.
Published: (2023-05-01)

Managing proliferative diabetic retinopathy in a patient with vitreous hemorrhage: a case report
by: O. B. Koshchynets, et al.
Published: (2022-06-01)

Efficacy of anti-VEGF combined with compound trabeculectomy in the treatment of neovascular glaucoma
by: Cao-Yu Sun, et al.
Published: (2020-09-01)